Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Aviron and Medeva extend FluMist collaboration

Aug. 2, 1999

Cangene product for prevention of hemolytic disease approved in U.K.

July 29, 1999

Avant Immunotherapeutics' rotavirus vaccine effective in infants

July 29, 1999

FDA advisory committee OKs safety and efficacy of Rapamune

July 28, 1999

Eligix cleared to initiate pivotal trial of DLI purification technology

July 28, 1999

AHP's pneumococcal conjugate vaccine receives priority review status

July 27, 1999

ProdiGene patents edible vaccines

July 23, 1999

Inhibitors of Src family SH2 domains in early-stage development at Boehringer Ingelheim

July 22, 1999

Novartis exercises option to license complement inhibitor from Avant

July 21, 1999

Rotavirus vaccine temporarily suspended due to reports of intussusception

July 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.